The independent director was designed to check management on behalf of dispersed shareholders. In India, however, most listed companies are controlled by a promoter or promoter group, so the central conflict lies between the controlling shareholder and the minority. This study asks whether Indian law can make an independent director independent of the promoter, and not merely of management. It adopts a doctrinal method with a limited functional comparison. It separates formal independence (eligibility status) from substantive independence (the capacity to disagree with those in control). It proposes five conditions through which the two can be examined: the appointing authority, tenure and removal, economic dependence, information and deliberation, and liability and enforcement. The Companies Act, 2013, the SEBI LODR Regulations, 2015 and three Supreme Court decisions are analysed against these conditions. The position in the United States, the United Kingdom, Singapore, Hong Kong, Germany, Israel and Italy is then compared. Five corporate episodes (Satyam, IL&FS, Fortis and Religare, DHFL, and Yes Bank) illustrate the law in operation. The study finds that Indian law is strong on verifiable formal matters such as tenure, remuneration and committee composition. It is weakest on who decides and what the decider knows. The special resolution under regulation 25(2A) is a real constraint, but promoter influence persists in nomination, board evaluation and the quality of information reaching independent directors. The hypothesis is therefore supported in a qualified form. The study offers an Independence Effectiveness Framework and suggests reforms: defining independence by reference to the promoter group, a majority-of-the-minority vote, evaluation led by independent directors, a clearer diligence standard under section 149(12), and a lower threshold for minority relief.
No takes yet. Share an insight, caveat, or question.
Jeyasuriya. K (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: